Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease

RECOMMENDED

Alzheimer’s Disease

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease

N Engl J Med.

Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, Mo Y, Sur C, Michelson D

doi: 10.1056/

Alzheimer’s Disease

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

Neuroimage Clin.

Chincarini A, Peira E, Morbelli S, Pardini M, Bauckneht M, Arbizu J, Castelo-Branco M, Büsing KA, de Mendonça A, Didic M, Dottorini M, Engelborghs S, Ferrarese C, Frisoni GB, Garibotto V, Guedj E, Hausner L, Hugon J, Verhaeghe J, Mecocci P, Musarra M, Queneau M, Riverol M, Santana I, Guerra UP, Nobili F

doi: 10.1016/j.nicl.2019.101846.

Targeting prodromal Alzheimer's disease: too late for prevention?

Lancet Neurol.

Yassine HN

doi: 10.1016/

Aging and Cognitive FunctionsDementia

Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia

Curr Treat Options Neurol.

Sheikh-Bahaei N, Sajjadi SA, Pierce AL

doi: 10.1007/

Aging and Cognitive FunctionsDementia

Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease

Brain.

Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative* and the PREVENT-AD Research Group

doi: 10.1093/brain/awy093.

Dementia

Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data

Neuroimage Clin.

Sörensen A, Blazhenets G, Rücker G, Schiller F, Meyer PT, Frings L; Alzheimer's Disease Neuroimaging Initiative

doi: 10.1016/j.nicl.2018.101637.

Dementia

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET

Eur J Nucl Med Mol Imaging.

Brendel M, Schnabel J, Schönecker S, Wagner L, Brendel E, Meyer-Wilmes J, Unterrainer M, Schildan A, Patt M, Prix C, Ackl N, Catak C, Pogarell O, Levin J, Danek A, Buerger K, Bartenstein P, Barthel H, Sabri O, Rominger A

doi: 10.1007/

Aging and Cognitive FunctionsAlzheimer’s Disease

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

JAMA Neurol.

Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsDementia

Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation

J Alzheimers Dis.

Padovani A, Benussi A, Cantoni V, Dell'Era V, Cotelli MS, Caratozzolo S, Turrone R, Rozzini L, Alberici A, Altomare D, Depari A, Flammini A, B Frisoni G, Borroni B

doi: 10.3233/JAD-180293.

Related content

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

Targeting prodromal Alzheimer's disease: too late for prevention?

Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia

Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease

Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation